Introducing the innovative Coronary Artery Calcium Treatment, brought to you by Shanghai Soulbay Medical Technology Co., Ltd., a leading manufacturer, supplier, and factory based in China. Our product signifies a breakthrough in cardiac care, revolutionizing the diagnosis and treatment of atherosclerosis. Coronary artery calcium scoring, also known as CAC scoring, plays a critical role in assessing the risk of developing heart disease by measuring the calcified plaque accumulation within the coronary arteries. With our cutting-edge technology and expertise in medical advancements, the Coronary Artery Calcium Treatment offers a sophisticated and accurate solution for healthcare professionals worldwide. This non-invasive imaging technique assists in detecting and quantifying the amount of calcium present in the coronary arteries, allowing for timely and personalized treatment plans to be developed for patients at risk of cardiovascular diseases. Our dedicated team at Shanghai Soulbay Medical Technology Co., Ltd. strives to provide high-quality products that adhere to international standards. We are committed to offering comprehensive after-sales support and training to ensure the successful implementation of this groundbreaking technology in hospitals, clinics, and research facilities globally. Trust in our expertise and join us in making cardiac care more precise, accessible, and life-saving.